Clinical Trial Update: A Phase 1-2 Study of CF102 in Patients With Advanced Hepatocellular Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

Phase 1-2 trial of CF102 in advanced hepatocellular carcinoma completed; results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• CF102 (piclidenoson)

Snippet

Sponsor: Can-Fite BioPharma | Conditions: Hepatocellular Carcinoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2015-02-27